Yes, enhanced monitoring is necessary including glucose parameters every 3 months, comprehensive metabolic panels every 36 months, periodic IGF-1 levels, and clinical surveillance for gastrointestinal symptoms, gallbladder disease, and growth hormone-related effects
Studies using gene array analysis have reported that GHK-Cu modulates the expression of hundreds of human genes including genes involved in tissue remodelling, inflammation regulation, DNA repair, antioxidant defence, and cellular metabolism making it a uniquely broad-spectrum research tool for studying peptide-driven gene regulation
No significant adverse effects were reported at doses up to 1mg per day over 24 weeks
The contributors share their personal experience, recommendations of treatments, foods, medications, supplements and products for informative and educational purposes only
Gently swirl the vial or roll it between your palms until the powder dissolves completely